هفته نامه اطلاع رسانی اختراعات منتشر شده در سازمان جهانی مالکیت فکری
invbazaar.com

سالهفتهIDTitleApplNoIPCApplicantSubgroupزیر گروهرشته شرحDescription
202546WO/2024/196438FLUORINATED MU-OPIOID RECEPTOR AGONISTSUS2023/082355C07D 235/06THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICESCHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202546WO/2025/132929SALTS OF AVATROMBOPAGEP2024/087614C07D 401/14SYNTHON B.VCHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202546WO/2025/207482DIARYLPIPERIDONE HYBRID CONJUGATES AND METHODS OF USE THEREOFUS2025/021092C07D 211/74AUGUSTA UNIVERSITY RESEARCH INSTITUTE, INC.CHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202546WO/2025/212514METHODS OF TREATING INFLAMMATORY DISEASESUS2025/022323C07D 498/18INTERLINE THERAPEUTICS, INC.CHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202546WO/2025/214474Adenosine receptor selective ligandsCN2025/088502C07D 213/85SHAOXING CITY YOULUOFEI PHARMACEUTICAL CO., LTD.CHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202546WO/2025/231561TERTIARY AMINE-SUBSTITUTED BIPYRIDINE COMPOUNDS, COMPOSITIONS COMPRISING THEM, AND THEIR USE AS PHARMACEUTICALSCA2025/050671C07D 417/14UNIVERSITE DE MONTREALCHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202546WO/2025/231563SUBSTITUTED TRICYCLIC COMPOUNDS, COMPOSITIONS COMPRISING THEM, AND THEIR USE AS PHARMACEUTICALSCA2025/050674C07D 498/14UNIVERSITE DE MONTREALCHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202546WO/2025/231587ANHYDROUS CRYSTAL FORM CH OF RESMETIROM AND PREPARATION METHOD THEREFORCN2024/091216C07D 403/12HANGZHOU CHEMINSPIRE TECHNOLOGIES CO., LTD.CHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202546WO/2025/231630NAMPT MODULATORS, PREPARATIONS, AND USES THEREOFCN2024/091582C07D 263/58SIRONAX (BEIJING) CO., LTD.CHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202546WO/2025/232047METHOD FOR KETALIZING SHIKIMIC ACID ESTER TO SYNTHESIZE SHIKIMIC ACID ETHERATECN2024/116188C07D 317/46ZHEJIANG DELEKANG FOOD CO., LTD.CHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202546WO/2025/232063NOVEL SCAFFOLD 99MTC-FAPI DIAGNOSTIC PROBE AND USE THEREOF IN PREPARATION OF DRUG OR REAGENT FOR DIAGNOSING TUMORCN2024/120541C07D 401/14NANJING NUOYUAN MEDICAL DEVICES CO., LTDCHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202546WO/2025/232085IMIDAZOTHIADIAZOLE COMPOUNDS AS WELL AS PREPARATION METHOD THEREFOR AND USE THEREOFCN2024/124352C07D 513/04BEIJING HESU PHARMACEUTICALS INC.CHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202546WO/2025/232118FUSED RING COMPOUND AS WELL AS PREPARATION METHOD THEREFOR AND USE THEREOFCN2024/129466C07D 403/14SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.CHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202546WO/2025/232344ETHYNYL-CONTAINING AZOLOL COMPOUND AND USE THEREOFCN2025/082481C07D 249/10SHENYANG PHARMACEUTICAL UNIVERSITYCHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202546WO/2025/232387ARYLAMINE COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE AND ELECTRONIC APPARATUSCN2025/085915C07D 493/00SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD.CHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202546WO/2025/232388ARYLAMINE COMPOUND, ORGANIC ELECTROLUMINESCENT APPARATUS, AND ELECTRONIC DEVICECN2025/085916C07D 491/048SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD.CHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202546WO/2025/232411ORGANIC COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE, AND ELECTRONIC DEVICECN2025/087005C07D 403/10SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD.CHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202546WO/2025/232554COMPOUND DESIGNED ON BASIS OF CRBN E3 UBIQUITIN LIGASE AND USE OF COMPOUNDCN2025/090856C07D 401/14GLUETACS THERAPEUTICS (SHANGHAI) CO., LTD.CHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202546WO/2025/232650KIF18A INHIBITOR AS WELL AS PREPARATION METHOD THEREFOR AND USE THEREOFCN2025/092107C07D 491/048NANJING SYNNOCARE PHARMACEUTICAL TECHNOLOGY CO., LTD.CHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202546WO/2025/232665MESOIONIC PYRIMIDINIUM COMPOUND AND USE THEREOFCN2025/092242C07D 471/04QINGDAO KINGAGROOT CHEMICAL COMPOUND CO., LTD.CHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202546WO/2025/232693NOVEL COMPOUNDS, COMPOSITIONS COMPRISING THE SAME AND USES THEREOFCN2025/092530C07D 487/14NUPHASE THERAPEUTICS (SHANGHAI) LIMITED., CO.CHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202546WO/2025/232711NEW DEUTERIUM-CONTAINING PYRAZOLONE COMPOUND, AND PHARMACEUTICAL COMPOSITION AND USE THEREOFCN2025/092791C07D 403/04NANJING ZHIHE MEDICINE TECHNOLOGY CO., LTD.CHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202546WO/2025/232712CD9 INHIBITORS, PHARMACEUTICAL COMPOSITION, AND USES THEREOFCN2025/092794C07D 519/00THE CHINESE UNIVERSITY OF HONG KONGCHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202546WO/2025/232839NLRP3 INFLAMMASOME INHIBITORS AND USES THEREOFCN2025/093470C07D 471/04INSILICO MEDICINE IP LIMITEDCHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202546WO/2025/232848SALT-INDUCIBLE KINASES (SIK) INHIBITORS AND METHODS OF USES THEREOFCN2025/093538C07D 471/04INSILICO MEDICINE IP LIMITEDCHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202546WO/2025/232874PROCESS OF MAKING A MENIN-MLL INHIBITORCN2025/093750C07D 495/04KURA ONCOLOGY, INC.CHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202546WO/2025/232876OXY-AMIDE DERIVATIVES, PREPARATION METHOD AND MEDICAL USE THEREOFCN2025/093774C07D 405/04JIANGSU HANSOH PHARMACEUTICAL GROUP CO., LTD.CHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202546WO/2025/232877SALT-INDUCIBLE KINASES (SIK) INHIBITORSCN2025/093779C07D 487/04INSILICO MEDICINE IP LIMITEDCHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202546WO/2025/232878SUBSTITUTED PHENYL-CONTAINING AMINE COMPOUND, AND PREPARATION METHOD THEREFOR AND USE THEREOFCN2025/093780C07D 277/82VIGONVITA LIFE SCIENCES CO., LTD.CHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202546WO/2025/232887WEE1 DEGRADERS AND USES THEREOFCN2025/093827C07D 471/04SHANGHAI DEGRON BIOMEDICAL TECHNOLOGY CO., LTD.CHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202546WO/2025/232888WEE1 DEGRADERS AND USES THEREOFCN2025/093829C07D 471/04SHANGHAI DEGRON BIOMEDICAL TECHNOLOGY CO., LTD.CHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202546WO/2025/232903C-KIT(V559D)/PDGFRβ DOUBLE-TARGET ALLOSTERIC INHIBITOR, AND PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION COMPRISING SAME, AND USE THEREOFCN2025/093916C07D 213/75NATURAL PRODUCTS RESEARCH CENTER OF GUIZHOU PROVINCECHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202546WO/2025/232904TEGOPRAZAN MONOETHYL FUMARATE, AND PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION THEREOF AND USE THEREOFCN2025/093920C07D 405/12SHANGHAI NEO-LEADING PHARMATECH CO., LTDCHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202546WO/2025/232907ALKYNYL-SUBSTITUTED BI-HETEROCYCLIC DERIVATIVE, AND PREPARATION METHOD THEREFOR AND USE THEREOFCN2025/093945C07D 471/04CHENGDU CHIPSCREEN PHARMACEUTICAL LTD.CHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202546WO/2025/233174BENZIMIDAZOLE DERIVATIVES AS CGAS INHIBITORSEP2025/061669C07D 491/048BOEHRINGER INGELHEIM INTERNATIONAL GMBHCHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202546WO/2025/233384MICROBIOCIDAL PYRAZOLE COMPOUNDSEP2025/062451C07D 401/04SYNGENTA CROP PROTECTION AGCHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202546WO/2025/233464PROCESS AND INTERMEDIATES FOR THE PREPARATION OF A PHOSPHOGLICERATE DEHYDROGENASE INHIBITOREP2025/062641C07D 209/42CHIESI FARMACEUTICI S.P.A.CHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202546WO/2025/233465PROCESS AND INTERMEDIATES FOR THE PREPARATION OF A PHOSPHOGLICERATE DEHYDROGENASE INHIBITOREP2025/062643C07D 209/42CHIESI FARMACEUTICI S.P.A.CHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202546WO/2025/233481NEK7 DEGRADERS AND METHODS OF USE THEREOFEP2025/062671C07D 405/14CAPTOR THERAPEUTICS S.A.CHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202546WO/2025/233522SYNTHETIC PROCESS FOR AN ECTEINASCIDINEP2025/062773C07D 515/22PHARMA MAR, S.A.CHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202546WO/2025/2338374H-PYRIMIDO[1,2-A]PYRIMIDIN-4-ONE DERIVATIVES FOR USE AS NLRP3 INFLAMMASOME INHIBITORS FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERIB2025/054740C07D 487/04TAKEDA PHARMACEUTICAL COMPANY LIMITEDCHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202546WO/2025/233863ENPP1 INHIBITORSIB2025/054803C07D 487/04RE VENTURES I, LLCCHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202546WO/2025/233865ENPP1 INHIBITORSIB2025/054805C07D 487/04RE VENTURES I, LLCCHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202546WO/2025/233901ACTIVATORS OF PYRUVATE KINASE ISOFORM M2 AND METHODS FOR TREATING NEURODEGENERATIVE DISEASEIB2025/054891C07D 417/12BIOHAVEN THERAPEUTICS LTD.CHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202546WO/2025/233968A PROCESS FOR THE PREPARATION OF IMEGLIMIN COMPOUNDSIN2025/050724C07D 251/10COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCHCHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202546WO/2025/233973A PROCESS FOR PREPARATION OF AMORPHOUS DAPAGLIFLOZININ2025/050730C07D 309/10TITAN PHARMAPLUS PVT. LTD.CHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202546WO/2025/234174METHOD FOR PRODUCING FURAN-2,5-DICARBOXYLIC ACIDJP2025/003764C07D 307/68MITSUBISHI GAS CHEMICAL COMPANY, INC.CHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202546WO/2025/234404PYRIMIDINE-CONTAINING CONDENSED RING COMPOUND AND USE THEREOFJP2025/016569C07D 471/04ZENYAKU KOGYO CO., LTD.CHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202546WO/2025/234887NEK7 DEGRADERS AND METHODS OF USE THEREOFPL2024/000026C07D 401/14CAPTOR THERAPEUTICS S.A.CHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202546WO/2025/234888NEK7 DEGRADERS AND METHODS OF USE THEREOFPL2024/000027C07D 405/14CAPTOR THERAPEUTICS S.A.CHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202546WO/2025/235298BIFUNCTIONAL COMPOUNDS CONTAINING THIAZOLYL DERIVATIVES FOR DEGRADING CERTAIN CYCLIN-DEPENDENT KINASE VIA UBIQUITIN PROTEASOME PATHWAYUS2025/027391C07D 417/14NIKANG THERAPEUTICS, INC.CHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202546WO/2025/235331BIFUNCTIONAL COMPOUNDS CONTAINING PYRAZOLOPYRIMIDINE DERIVATIVES FOR DEGRADING CERTAIN CYCLIN-DEPENDENT KINASE VIA UBIQUITIN PROTEASOME PATHWAYUS2025/027636C07D 487/04NIKANG THERAPEUTICS, INC.CHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202546WO/2025/235362INDOLINONE COMPOUNDS AS KCa3.1 POTASSIUM CHANNEL BLOCKERSUS2025/027715C07D 209/34D. E. SHAW RESEARCH, LLCCHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202546WO/2025/235363CYCLIN-DEPENDENT KINASE 4 DEGRADERSUS2025/027717C07D 487/04BLUEPRINT MEDICINES CORPORATIONCHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202546WO/2025/235367AZAINDOLINONE COMPOUNDS AS KCA3.1 POTASSIUM CHANNEL BLOCKERSUS2025/027726C07D 471/04D. E. SHAW RESEARCH, LLCCHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202546WO/2025/235527CRYSTALLINE FORMS OF A PPAR ALPHA ANTAGONISTUS2025/028011C07D 249/12TEMPEST THERAPEUTICS, INC.CHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202546WO/2025/235600PROCESSES FOR THE PREPARATION OF SUBSTITUTED 3-((3-AMINOPHENYL)AMINO) PIPERIDINE-2,6-DIONE COMPOUNDSUS2025/028131C07D 211/92BRISTOL-MYERS SQUIBB COMPANYCHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202546WO/2025/235686FLUOROCAMPTOTHECIN COMPOUNDS, CONJUGATES, AND METHODS THEREOFUS2025/028255C07D 491/22AARVIK THERAPEUTICS, INC.CHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202546WO/2025/235733BIS-BICYCLOHETEROARYL MACROCYCLES AND THEIR USEUS2025/028355C07D 487/14BLOSSOMHILL THERAPEUTICS, INC.CHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202546WO/2025/235784ERGOLINE DERIVATIVES AND USES THEREOFUS2025/028442C07D 457/06CY BIOPHARMA AGCHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202546WO/2025/235797POTENT ASGPR-BINDING HETEROBIFUNCTIONAL COMPOUNDS COMPRISING ANTIBODIES FOR THE DEGRADATION OF TARGETED PROTEINSUS2025/028469C07D 401/12AVILAR THERAPEUTICS, INC.CHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202546WO/2025/235800ERGOLINE DERIVATIVES AND USES THEREOFUS2025/028473C07D 457/06CY BIOPHARMA AGCHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202546WO/2025/235872HETEROCYCLICS AS EGFR INHIBITORSUS2025/028620C07D 487/04SCHRÖDINGER, INC.CHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202546WO/2025/235874HETEROCYCLICS AS EGFR INHIBITORSUS2025/028622C07D 239/94SCHRÖDINGER, INC.CHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی
202546WO/2025/235957P53 MUTANT STABILIZER AND USES THEREOFUS2025/028753C07D 401/12FRONTIER MEDICINES CORPORATIONCHEMISTRY; METALLURGYعلم شیمی؛ متالورژیشیمی